Insights

NIH Funding Signal InBio recently secured a $3.5M NIH grant to advance allergy research, indicating strong potential for collaboration on funded projects and renewed demand for advanced diagnostic and research tools.

Circular Ops Partnership with Polycarbin to recycle lab plastics and implement circular solutions shows a commitment to sustainable operations, presenting an opportunity to offer waste reduction, sustainable sourcing, and compliance solutions to customers.

Allergen Portfolio A broad product catalog spanning purified allergens, test kits, and allergen testing services positions InBio as a one-stop supplier for allergy diagnostics, enabling cross-sell of ELISA kits, MARIA technologies, and mass spec services.

Strategic Partnerships Existing collaborations with GX Group and LGC Standards suggest receptiveness to distribution and co-development arrangements, making channel partnerships and co-branded products viable sales avenues.

Growth Readiness Revenue in the $10–25M range with ongoing R&D focus and rapid product evolution (ELISA 2.0, MARIA for Foods, human IgE antibodies) indicates readiness for large customers, academic labs, and contract research opportunities seeking cutting-edge allergy solutions.

Similar companies to InBio

InBio Tech Stack

InBio uses 8 technology products and services including QuickBooks, Amazon Web Services, WordPress, and more. Explore InBio's tech stack below.

InBio's Email Address Formats

InBio uses at least 4 email formats:
InBio Email FormatsExamplePercentage
FLast@inbio.comJDoe@inbio.com
71%
Last@inbio.comDoe@inbio.com
17%
First@inbio.comJohn@inbio.com
7%
First.Last@inbio.comJohn.Doe@inbio.com
5%

Frequently Asked Questions

What is InBio's stock symbol?

Minus sign iconPlus sign icon
InBio is a publicly traded company; the company's stock symbol is SBTX.L.

What is InBio's official website and social media links?

Minus sign iconPlus sign icon
InBio's official website is inbio.com and has social profiles on LinkedIn.

How much revenue does InBio generate?

Minus sign iconPlus sign icon
As of August 2026, InBio's annual revenue is estimated to be $10M - $25M.

What is InBio's SIC code and NAICS code?

Minus sign iconPlus sign icon
InBio's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does InBio have currently?

Minus sign iconPlus sign icon
As of August 2026, InBio has approximately 57 employees across 3 continents, including North America, Europe and Asia. Key team members include European Business Director: H. G. M., Commercial Manager: R. Y. and Operations Manager: S. D. Explore InBio's employee directory with LeadIQ.

What industry does InBio belong to?

Minus sign iconPlus sign icon
InBio operates in the Biotechnology Research industry.

What technology does InBio use?

Minus sign iconPlus sign icon
InBio's tech stack includes QuickBooks, Amazon Web Services, WordPress, Mailchimp, Microsoft 365, Intercom, Zendesk Chat and Algolia.

What is InBio's email format?

Minus sign iconPlus sign icon
InBio's email format typically follows the pattern of FLast@inbio.com. Find more InBio email formats with LeadIQ.
InBio logo

InBio

Biotechnology ResearchVirginia, United States51-200 Employees

InBio is a mid-sized biotechnology research company focused on allergens, offering a broad catalog of purified allergens, advanced diagnostic test kits, and services for environmental and food allergen testing, as well as contract research for specialized needs. Its value lies in deep scientific expertise, ongoing commitment to R&D, and direct access to its scientific team, enabling researchers and diagnostic developers to advance allergy-related work without relying on fragmented suppliers. The company emphasizes flexible, collaborative relationships to support projects across primary research, diagnostics, and product development.

Based in Charlottesville, Virginia, InBio operates in the biotechnology research sector, serving researchers conducting primary allergen studies, diagnostic developers, and organizations requiring allergen testing or CRO-like support. Recent collaborations include a partnership with GX Group to develop and manufacture a project named Apollo, reflecting its active engagement with industry partners to broaden capabilities.

Section iconCompany Overview

Website
inbio.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
SBTX.L
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $10M - $25M

    InBio's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.